Wednesday, July 9, 2025
23.8 C
London
HomeFinTechMedlab Clinical: Recieves Australian patent for NanoCelle

Medlab Clinical: Recieves Australian patent for NanoCelle

Date:

AusPayNet and AP+ Launch Consultation on the Future of Australian A2A Payments

AusPayNet and Australian Payments Plus begin public consultation to...

Ziglu Enters Administration: What It Means for Customers and Crypto

Understanding the Implications for Users Amidst Financial TurmoilHighlights: Ziglu...

Lloyds Launches Innovative Two-Month Data and AI Summer School for Employees

Empowering Workforce through Extensive Training in Data Science and...
  • Biotech company Medlab Clinical (MDC) has been granted an Australian patent for its NanoCelle delivery platform
  • Essentially, NanoCelle delivers drug formulations via an oral spray
  • So far, product testing results have indicated the spray can lead to better absorption of the drugs, helping the formulation avoid ingested routes
  • It can also potentially lower drug dosages and reduce the side effects of some formulations
  • Medlab has also filed patent applications in other jurisdictions, such as the U.S., Europe and New Zealand
  • On the market this afternoon, Medlab is up 3.03 per cent, trading for 17 cents per share

Related stories

spot_img

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories